Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • PrimeView
  • Published:

Antiphospholipid syndrome

Nature Reviews Disease Primers volume 4, Article number: 17104 (2018) Cite this article

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Antiphospholipid syndrome (APS) is an autoimmune disease characterized by the presence of antiphospholipid antibodies, such as lupus anticoagulant, anticardiolipin antibodies and anti-β2-glycoprotein 1 antibodies. This PrimeView focuses on the pathophysiology of APS, which is mainly characterized by thrombosis and obstetrical complications.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Antiphospholipid syndrome. Nat Rev Dis Primers 4, 17104 (2018). https://doi.org/10.1038/nrdp.2017.104

Download citation

  • Published:

  • DOI: https://doi.org/10.1038/nrdp.2017.104

Search

Advanced search

Quick links